David Grinblatt to Dexamethasone
This is a "connection" page, showing publications David Grinblatt has written about Dexamethasone.
Connection Strength
0.045
-
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study. JAMA Oncol. 2022 09 01; 8(9):1278-1286.
Score: 0.045